The Crypto.com Showdown was full of playful banter—and that included a playful jab from Rory McIlroy at Charles Barkley.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 488.46% and ...

The Food and Drug Administration (FDA) said Tuesday in a statement it has sent warning letters to companies selling ...

PGA Tour star Rory McIlroy had a fun back-and-forth with Basketball Hall of Famer Charles Barkley during "The Showdown" in ...

The woman was accused of selling counterfeit versions of popular weight loss drugs, including Ozempic and Wegovy. Experts say ...

GLP-1 receptor agonist drugs like Ozempic, Wegovy and Mounjaro have helped millions of Americans lose weight and better ...

We recently compiled a list of the 12 Best Weight Loss Stocks to Buy According to Hedge Funds. In this article, we are going ...

Eli Lilly's key products, Mounjaro and Zepbound, dominate the U.S. weight loss market. Read more to see why I rate LLY stock ...

Conagra Brands will introduce an On Track label on some of its Healthy Choice ready meals to cater to users of GLP-1 drugs ...

Californian food tech startup One Bio has closed $27M Series A round for its short-chain fibre ingredients derived from ...

Weight loss drugs, compounding, vitamin D, and AI all piqued readers’ interest — and sometimes, ire — this past year.

On the other hand, the nature of its industry means that there will often be solid new reasons to be a bit more cautious ...